You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Azelastine Hydrochloride And Fluticasone Propionate, and what generic alternatives are available?

Azelastine Hydrochloride And Fluticasone Propionate is a drug marketed by Apotex and Padagis Israel and is included in two NDAs.

The generic ingredient in AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE is azelastine hydrochloride; fluticasone propionate. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride; fluticasone propionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Azelastine Hydrochloride And Fluticasone Propionate

A generic version of AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE was approved as azelastine hydrochloride; fluticasone propionate by APOTEX on April 28th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE?
  • What are the global sales for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE?
  • What is Average Wholesale Price for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE?
Summary for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
US Patents:0
Applicants:2
NDAs:2
Finished Product Suppliers / Packagers: 3
Clinical Trials: 16
What excipients (inactive ingredients) are in AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE?AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE excipients list
DailyMed Link:AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE at DailyMed
Drug patent expirations by year for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
Recent Clinical Trials for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Humanis Saglık Anonim SirketiPhase 1
Wuhan Union Hospital, ChinaPhase 4
Zheng Liu ENTPhase 4

See all AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE clinical trials

Pharmacology for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

US Patents and Regulatory Information for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE azelastine hydrochloride; fluticasone propionate SPRAY, METERED;NASAL 207712-001 Apr 28, 2017 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Israel AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE azelastine hydrochloride; fluticasone propionate SPRAY, METERED;NASAL 208111-001 Feb 18, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.